Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Pulmonology
•
Pulmonary Vascular Disease
•
Hospital Medicine
What patient related factors and hemodynamic parameters would lead you to avoid transbronchial biopsies in patients with pulmonary hypertension?
Answer from: at Community Practice
I try to avoid if INR is > 1.7 or platelet count is less than 30,000 in patients who have Grp I PAH.
Sign in or Register to read more
14421
Related Questions
How do you manage concurrent non-life-threatening hemoptysis and acute pulmonary embolism?
In cases of intermediate-risk pulmonary embolism, what factors influence your decision to pursue catheter-directed thrombolysis?
For patients with newly diagnosed VTE on IV heparin planned for transition to DOAC, would you start at the loading or maintenance DOAC dose?
What is your approach to withdrawal of ventilatory support at the end of life?
Does the use of NIV for pre-oxygenation delay the time to intubation?
Is the adage “If GCS <8, intubate” still relevant for non-TBI patients?
What are first-line choices for vasopressors/inotropes to use in hypotensive patients with Eisenmenger Syndrome?
Do you use anticoagulants in the management of patients with pulmonary veno-occlusive disease (PVOD)?
What would be your approach to percutaneous intervention for acute plaque rupture and cardiogenic shock for a patient with cirrhosis and severe thrombocytopenia?
Would you consider antifungal prophylaxis for immunocompromised patients with COVID-19 requiring mechanical ventilation, considering the high risk of invasive pulmonary aspergillosis in patients with severe COVID-19?